Laxmi Organic Industries approves Q2 FY27 results and appoints new director

Laxmi Organic Industries announced its unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The company’s Board of Directors also approved the appointment of Mr. Rajesh Naik as an Additional Director and Whole-time Director, designated as Executive Director (Operations), effective November 6, 2026. Further, the Board approved seeking shareholder approval for the appointment of Mr. Harshvardhan Goenka as Managing Director & Chief Executive Officer.

Quarter ended Six months ended Year ended
30.09.2026
(Unaudited)
30.06.2026
(Unaudited)
30.09.2025
(Unaudited)
30.09.2026
(Unaudited)
30.09.2025
(Unaudited)
31.03.2026
(Audited)
Revenue from Operations 10,546.27 9,577.28 7,064.20 20,123.55 13,783.29 28,085.32
Total income 10,577.91 9,611.55 7,103.24 20,189.46 13,877.39 28,237.26
Total expenses 9,912.40 8,762.63 6,914.63 18,675.03 13,511.25 27,311.44
Profit before tax 665.51 848.92 188.61 1,514.43 366.14 925.82
Profit after tax for the period/year 498.64 632.95 139.37 1,131.59 369.07 792.58
Unaudited Standalone Financial Results for the quarter and six months period ended September 30, 2026.

Board Meeting Outcome

On November 5, 2026, Laxmi Organic Industries Limited held a Board meeting where several key decisions were made. The Board reviewed and approved the unaudited standalone and consolidated financial results for the quarter and six months ending September 30, 2026. These results, along with the Limited Review Report, have been submitted to the stock exchanges.

Key Appointments Approved

A significant outcome of the meeting was the approval for the appointment of Mr. Rajesh Naik (DIN: 06935998) as an Additional Director and a Whole-time Director, designated as Executive Director (Operations). This appointment is effective from November 6, 2026, for a term of five years, subject to shareholder approval. Mr. Naik brings over 34 years of experience in the chemical industry.

Furthermore, the Board approved seeking shareholder approval through a postal ballot for the appointment and re-designation of Mr. Harshvardhan Goenka as Managing Director & Chief Executive Officer of the Company. The company also announced that details pertaining to Mr. Goenka’s appointment were submitted to the stock exchanges on September 08, 2026.

Financial Results Highlights

The unaudited standalone financial results show a profit after tax of ₹498.64 million for the quarter ended September 30, 2026, compared to ₹139.37 million in the corresponding prior period. For the six months ended September 30, 2026, the profit after tax stood at ₹1,131.59 million.

Consolidated results also reflect improved performance, with a profit after tax of ₹570.07 million for the quarter and ₹1,247.23 million for the six months ended September 30, 2026.

Disclosure of Appointments

Detailed information regarding the appointment of Mr. Rajesh Naik, including his brief profile, terms of appointment, and non-relatedness to existing directors, has been provided as per SEBI Listing Regulations. The company confirmed that Mr. Naik is not debarred from holding a director position.

Source: BSE

Previous Article

Symbiotec Pharmalab reports ₹2,800.40 crore total income in Q2 FY27